Stay up to date on the latest dietary supplement market trends happening in the digestive health category and learn about new innovations.
The industry’s leading manufacturer and supplier of nattokinase has announced the publication and noted approval of NSK-SD® nattokinase on the Union market as a novel food ingredient under the Article 1(2) of Regulation (EC) No 258/97. NSK-SD has been approved in all 28 EU member states and was featured in the Office Journal of the European Union. As expected, EFSA also noted that NSK-SD exhibits in vitro fibrinolytic activity and in vitro thrombolytic activity in animals when administered parenterally.
What is Nattokinase?
NSK SD® nattokinase is a potent fibrinolytic enzyme produced from the fermentation of boiled soybeans by B. subtilis. This process results in the traditional Japanese food, Natto, from where the enzyme gets its name.
NSK SD® nattokinase may help to normalize blood viscosity and pressure by degrading circulating fibrin. According to the manufacturer, NSK-SD® has been researched for more than 25 years, with results suggesting numerous circulatory benefits.
Here’s a link to the European law and all documentation associated with this approval of fermented soybean extract:
http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017D0115
